NIDA grant supports Camino Pharma's development of compounds for substance use disorders Sep. 29, 2017 No Comments
Aeolus Pharmaceuticals' AEOL-10150 safe and well-tolerated in phase I study Sep. 20, 2017 No Comments
Emergent Biosolutions awarded funding to develop antidote spray for cyanide poisoning Sep. 20, 2017 No Comments
FDA grants priority review to Braeburn's NDA for CAM-2038 for opioid use disorder Sep. 18, 2017 No Comments
Ophirex licenses sPLA2 inhibitor data from Lilly and Shionogi to support snakebite program Aug. 29, 2017 No Comments
Pluristem starts pilot study to test PLX-R18 cell therapy for acute radiation syndrome Aug. 17, 2017 No Comments
Soligenix receives additional NIAID funding for the development of heat stable ricin vaccine Aug. 16, 2017 No Comments